U.S. - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Apr 15, 2024

U.S. - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Medicaments Containing Insulin Price in the United States - 2023

Contents:

  1. Medicaments Containing Insulin Price in the United States (FOB) - 2022
  2. Medicaments Containing Insulin Price in the United States (CIF) - 2022
  3. Medicaments Containing Insulin Exports in the United States
  4. Medicaments Containing Insulin Imports in the United States

Medicaments Containing Insulin Price in the United States (FOB) - 2022

In 2022, the average medicaments containing insulin export price amounted to $45,675 per ton, rising by 3.7% against the previous year. In general, the export price, however, showed a abrupt decline. The pace of growth was the most pronounced in 2016 when the average export price increased by 10% against the previous year. Over the period under review, the average export prices reached the peak figure at $246,638 per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was China ($1,144,581 per ton), while the average price for exports to Denmark stood at $44,892 per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to China (+12.6%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Price in the United States (CIF) - 2022

In 2022, the average medicaments containing insulin import price amounted to $221,671 per ton, approximately reflecting the previous year. Over the period under review, the import price showed a abrupt slump. The most prominent rate of growth was recorded in 2019 an increase of 114% against the previous year. The import price peaked at $642,753 per ton in 2013; however, from 2014 to 2022, import prices stood at a somewhat lower figure.

Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Denmark ($226,078 per ton), while the price for the UK amounted to $219,503 per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (+13.2%).

Medicaments Containing Insulin Exports in the United States

In 2022, shipments abroad of medicaments containing insulin but not antibiotics decreased by -83.9% to 230 tons, falling for the second consecutive year after two years of growth. Overall, exports faced a sharp decline. The growth pace was the most rapid in 2020 with an increase of 33% against the previous year. As a result, the exports reached the peak of 2.4K tons. From 2021 to 2022, the growth of the exports failed to regain momentum.

In value terms, medicaments containing insulin exports declined significantly to $11M in 2022. Over the period under review, exports saw a precipitous contraction. The smallest decline of -8.4% was in 2020.

Export of Medicaments Containing Insulin in the United States (Million USD)
COUNTRY2019202020212022CAGR,
2019-2022
Denmark10610958.710.3-54.0%
Brazil14.60.1N/AN/A-99.3%
Others1.32.44.30.2-46.4%
Total12211263.010.5-55.8%

Top Export Markets for Medicaments Containing Insulin from the United States in 2022:

  1. Brazil (undefined tons)
  2. Denmark (228.5 tons)

Medicaments Containing Insulin Imports in the United States

Medicaments containing insulin imports into the United States expanded modestly to 161 kg in 2022, increasing by 2.5% on 2021. In general, total imports indicated a strong increase from 2019 to 2022: its volume increased at an average annual rate of +19.6% over the last three years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -2.4% against 2020 indices. The growth pace was the most rapid in 2020 when imports increased by 76%. As a result, imports attained the peak of 165 kg. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports stood at $36K in 2022. Overall, imports saw a significant increase. The pace of growth appeared the most rapid in 2020 with an increase of 122% against the previous year. As a result, imports attained the peak of $36K. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

Import of Medicaments Containing Insulin in the United States (Thousand USD)
COUNTRY2019202020212022CAGR,
2019-2022
United Kingdom9.836.126.123.734.2%
DenmarkN/AN/A5.612.0114.3%
Canada6.5N/A3.6N/A-25.6%
OthersN/AN/AN/AN/A0%
Total16.236.135.335.730.1%

Top Suppliers of Medicaments Containing Insulin to the United States in 2022:

  1. United Kingdom (108.0 kg)
  2. Denmark (53.0 kg)

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

  • United States

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in the U.S.
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023
Store
Blog
Event
U.S. - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 15, 2024
Eye 383

This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 6, 2024
Eye 330

This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..

U.S. - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 386

This report provides an in-depth analysis of the medicaments containing penicillin market in the U.S..

U.S. - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 274

This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..

U.S. - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 209

This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the U.S..

U.S. - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 183

This report provides an in-depth analysis of the market for medicaments of other antibiotics in the U.S..

World - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 15, 2024
Eye 475

This report provides an in-depth analysis of the global medicaments containing insulin market.

World - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 6, 2024
Eye 476

This report provides an in-depth analysis of the global medicaments containing hormones market.

World - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 1, 2024
Eye 564

This report provides an in-depth analysis of the global medicaments containing penicillin market.

World - Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
$599
Apr 13, 2024
Eye 302

This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.

Free Data: Medicaments Containing Insulin But Not Antibiotics - United States